Low
₹13.83
High
₹13.99
| Previous Close | ₹13.84 |
|---|---|
| Day's Range | ₹13.83 - ₹13.99 |
| Open | ₹13.86 |
| 52 Week Range | ₹12.50 - ₹16.00 |
| Volume | 1,51,731 |
| Market Cap |
| Trade Value ( ₹ in Lacs) | 21.00 |
|---|---|
| Market Cap (₹ in Mn) | |
| Dividend Yield(%) | |
| Price/Earning (TTM) | |
| TTM EPS (₹) | |
| P/E Ratio | |
| Book Value(₹) | |
| PAT Margin (%) | |
| Face Value (₹) | |
| ROCE(%) |
| NSE Symbol | NV20IETF |
|---|
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|
No Records Found
Mishtann Foods has informed that the meeting of the Board of Directors of the Company will be held on Saturday, August 08, 2026 at the Registered Office of the Company, to transact the following businesses: 1. To consider and approve Un-Audited Standalone & Consolidated Financial Statements / Results for Quarter ended June 30, 2026. 2. Any other business with the permission of the chair and the majority of the directors presents at the meeting. Further, pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for regulating, monitoring and reporting of trading by Insiders and Code of fair disclosure of unpublished price sensitive information, the trading window of the Company for the Quarter ended is already closed and shall reopen after expiry of 48 hours from declaration of Financial Results for Quarter ended June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Pursuant to the Regulation 29 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sahyadri Industries has informed that, Meeting of Board of Directors of the Company is scheduled to be held on Wednesday, 12th August 2026 to consider, the following businesses: The declaration of Interim Dividend, if any, for the Financial Year 2026-27; To consider the Record Date for the purpose of Interim Dividend for the Financial Year 2026-27, in case of the declaration of aforesaid Interim Dividend. Accordingly, Trading Window for dealing in securities is closed from 05th August, 2026 upon intimation (on 5th August 2026) to Stock exchanges for proposed Board Meeting for consideration of Interim Dividend for the Financial Year 2026-27 till 48 hours from declaration of Interim Dividend by the Board on 12th August 2026 (i.e till Friday, 14th August 2026).
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with circulars issued by SEBI, Emmbi Industries has informed that a meeting of the Board of Directors of the company is scheduled to be held on Friday, 14th August, 2026, to consider the following: 1. Approval of Un-audited Standalone & Consolidated Financial Results of the Company along with Limited Review Report from the Statutory Auditors of the Company for the quarter ended June 30, 2026; 2. Any other item with the permission of the chair. Further, as informed vide our letter dated 25th June, 2026, the trading window for dealing in the Company's Equity shares by the Directors, Promoters, KMP, Other Designated Persons and Specified Connected persons has already been closed with effect from 1st July, 2026 and the same shall open 48 hours after the conclusion of the Board Meeting.
The above information is a part of company’s filings submitted to BSE.
With reference to its Letter dated 4th August 2026 vide which it has submitted the unaudited Financial Results (Standalone and Consolidated) of the Company for the First Quarter ended 30th June 2026, Sudeep Pharma has submitted copies of the Extract of unaudited Financial Results of the Company for the First Quarter ended 30th June 2026, on Consolidated basis, published in Business Standard, English language newspaper, Ahmedabad and Vadodara Samachar and Gujarat Samachar, Regional language newspapers at Vadodara, Gujarat on 5th August, 2026. The above information is also available on the Company’s website at https://www.sudeeppharma.com/.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of ICICI Prudential Nifty50 Value 20 ETF is ₹13.84 as of 2026-08-05.
The market capitalisation of ICICI Prudential Nifty50 Value 20 ETF is ₹ as of .
The 1-year return of ICICI Prudential Nifty50 Value 20 ETF is -0.31% as of 2026-08-05.
The P/E ratio of ICICI Prudential Nifty50 Value 20 ETF is as of .
The 52-week high and low of ICICI Prudential Nifty50 Value 20 ETF are ₹ and ₹, respectively, as of 2026-08-05.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.